Hydrochloric Acid

Hydrochloric Acid

SCHEMBL222541

[Cl-].[Cl-].[Ni+2].c1ccc(PCCCPc2ccccc2)cc1

nearest known ligand 0.30

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
CA9 Q16790 2/20 0.30
CA12 O43570 1/20 0.30
GLA P06280 1/20 0.30
CA3 P07451 1/20 0.30
CA4 P22748 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CA14 Q9ULX7 1/20 0.30
CA7 P43166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4117722 1.00 CA1 (0.30) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL5107414 0.95 CA1 (0.30) CA1CA2CA9CA12GLA
SCHEMBL197099 0.95 CA1 (0.33) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL7165412 0.92 CA1 (0.32) CA1CA2CA9CA12GLA
SCHEMBL1398394 0.92 CA1 (0.32) CA1CA2CA9CA12GLA
SCHEMBL7769634 0.92 CA1 (0.32) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL7165413 0.92 CA1 (0.32) CA1CA2CA9CA12GLA
Bromide SCHEMBL5510644 0.90 CA1 (0.30) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL5107617 0.90 CA1 (0.30) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL222540 0.90 CA1 (0.30) CA1CA2CA9CA12GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2083033-B1 Organic semiconducting copolymer and organic electronic device including the same SAMSUNG ELECTRONICS CO LTD (KR) 2012-04-18 EP claimed
EP-1846472-B1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GMBH (DE) 2011-03-23 EP claimed
US-7807776-B2 Procees of preparing regioregular polymers MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-10-05 US claimed
US-7777221-B2 Organic semiconducting copolymer and organic electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-08-17 US claimed
US-20090189150-A1 Organic semiconducting copolymer and organic electronic device including the same SAMSUNG ELECTRONICS CO., LTD. 2009-07-30 US claimed
EP-2083033-A1 Organic semiconducting copolymer and organic electronic device including the same Samsung Electronics Co., Ltd. (KR) 2009-07-29 EP claimed
US-RE40813-E1 Polythiophenes, block copolymers made therefrom, and methods of forming the same CARNEGIE MELLON UNIVERSITY (US) 2009-06-30 US claimed
US-20090023887-A1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GESELLSCHAFT, MIT BESCHRANKTER HAFTUNG (DE) 2009-01-22 US claimed
EP-1654298-B1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GMBH (DE) 2008-10-01 EP claimed
US-7294288-B2 Process of preparing regioregular polymers MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2007-11-13 US claimed
EP-1028136-B1 A method of forming poly-(3-substituted) thiophenes UNIV CARNEGIE MELLON (US) 2006-05-24 EP claimed
US-20050080219-A1 Process of preparing regioregular polymers MERCK PATENT GMBH (DE) 2005-04-14 US claimed
US-20040030091-A1 Lightweight, electroconductivity, heat resistance MCCULLOUGH RICHARD D (US) 2004-02-12 US claimed
US-20040024171-A1 Stereospecific electroconductive polymers such as polyhexylthiophene-polystyrene or -polymethylacrylate copolymers, used as light emitting diodes, biosensors, transistors, displays or optical apparatus MCCULLOUGH RICHARD D (US) 2004-02-05 US claimed
US-6602974-B1 Conducting polymers, head-to-tail coupled regioregular polythiophenes, poly-(3-substituted) thiophene diol CARNEGIE MELLON UNIVERSITY 2003-08-05 US claimed
US-6166172-A Method of forming poly-(3-substituted) thiophenes CARNEGIE MELLON UNIVERSITY (US) 2000-12-26 US claimed
EP-1028136-A2 A method of forming poly-(3-substituted) thiophenes CARNEGIE-MELLON UNIVERSITY (US) 2000-08-16 EP claimed
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-05-16 US disclosed
US-5158957-A Dopamine antagonist SCHERING AKTIENGESELLSCHAFT (DE) 1992-10-27 US disclosed
US-5037832-A Dopaminergic agents for treating Parkinson*s disease SCHERING AKTIENGESELLSCHAFT (DE) 1991-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TDO2, SCO2, DUOX1 CA1 851/4885CA2 388/4885CA9 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.